JeffreyChristopherLa RochelleMD

PubMed

• 24 citations
  Prophylactic antibiotics following radical cystectomy reduces urinary tract infections and readmission for sepsis from a urinary source
  Ryan P. Werntz, Ann Martinez-Acevedo, Hamed Amadi, Ryan Kopp, Jeffrey C. La Rochelle, Theresa M. Koppie, Christopher L. Amling, Kamran P. Sajadi> ;Urologic Oncology. 2018 May 1
• Overnight Hospital Experiences for Medical Students: Results of the 2014 Clerkship Directors in Internal Medicine National Survey.
  Goren EN, Leizman DS, La Rochelle J, Kogan JR> ;J Gen Intern Med. 2015-09-01
• Cultivating Medical Education Research Mentorship as a Pathway Towards High Quality Medical Education Research.
  Blanchard RD, Visintainer PF, La Rochelle J> ;J Gen Intern Med. 2015-09-01
• 72 citations
  Timing, Incidence and Risk Factors for Venous Thromboembolism in Patients Undergoing Radical Cystectomy for Malignancy: A Case for Extended Duration Pharmacological Pr...
  Amanda VanDlac, Nick G. Cowan, Yiyi Chen, Ross Anderson, Michael J. Conlin, Jeffrey C. La Rochelle, Christopher L. Amling, Theresa M. Koppie> ;The Journal of Urology. 2014 Apr 1
• 4 citations
  Refining the use of cytoreductive nephrectomy in metastatic renal cell carcinoma
  Jeffrey C. La Rochelle, Christopher G. Wood, Axel Bex> ;Seminars in Oncology. 2013 Aug 1
• 12 citations
  Urological Manifestations of Sarcoidosis
  Jeffrey C. La Rochelle, Christopher L. Coogan> ;The Journal of Urology. 2012 Jan 1
• The feasibility, reliability, and validity of a post-encounter form for evaluating clinical reasoning.
  Durning SJ, Artino A, Boulet J, La Rochelle J, Van der Vleuten C, Arze B, Schuwirth L> ;Med Teach. 2012-01-01
• 4 citations
  Role of lymphadenectomy for prostate cancer: indications and controversies.
  Jeffrey C. La Rochelle, Christopher L. Amling> ;The Urologic Clinics of North America. 2011 Nov 1
• 63 citations
  Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma
  Jeffrey C. La Rochelle, Tobias Klatte, Aditi Dastane, Nagesh Rao, David Seligson, Jonathan W. Said, Brian Shuch, Nazy Zomorodian, Fairooz F. Kabbinavar, Arie S. Bellde...> ;Cancer. 2010 Oct 15
• Making use of contrasting participant views of the same encounter.
  Durning SJ, Artino A, Boulet J, Van Der Vleuten CPM, La Rochelle J, Arze B, Schuwirth L> ;Med Educ. 2010-10-01
• Contemporary management of renal tumors with venous tumor thrombus.
  Pouliot, F., Shuch, B., Larochelle, J.C., Pantuck, A., Belldegrun, A.S.> ;J Urol. 2010 Sep
• 7 citations
  Prostate cancer screening: what we have learned from the PLCO and ERSPC trials.
  Jeffrey C. La Rochelle, Christopher L. Amling> ;Current Urology Reports. 2010 Mar 30
• Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy.
  Shuch, B., Said, J., LaRochelle, J.C., Zhou, Y., Li, G., Klatte, T., Pouliot, F., Kabbinavar, F.F., Belldegrun, A.S., Pantuck, A.J.> ;Cancer. 2010-02-01
• 91 citations
  Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable?
  Brian Shuch, Jonathan W. Said, Jeff C. La Rochelle, Ying Zhou, Gang Li, Tobias Klatte, Fairooz F. Kabbinaavar, Allan J. Pantuck, Arie S. Belldegrun> ;The Journal of Urology. 2009 Nov 1
• 62 citations
  Functional and Oncological Outcomes of Partial Nephrectomy of Solitary Kidneys
  Jeffrey C. La Rochelle, Brian Shuch, Stephen B. Riggs, Li-Jung Liang, Ardavan Saadat, Fairooz F. Kabbinavar, Allan J. Pantuck, Arie S. Belldegrun> ;The Journal of Urology. 2009 May 1
• Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma.
  Klatte, T., Pantuck, A.J., Said, J.W., Seligson, D.B., Rao, N.P., LaRochelle, J.C., Shuch, B., Zisman, A., Kabbinavar, F.F., Belldegrun, A.S.> ;Clin Cancer Res. 2009-02-15
• Intraoperative thrombus embolization during nephrectomy and tumor thrombectomy: critical analysis of the University of California-Los Angeles experience.
  Shuch, B., Larochelle, J.C., Onyia, T., Vallera, C., Margulis, D., Pantuck, A.J., Smith, R.B., Belldegrun, A.S.> ;J Urol. 2009-02-01
• 4 citations
  Chemoprevention of bladder cancer
  Jeffrey C. La Rochelle, Ashish M. Kamat, H. Barton Grossman, Allan J. Pantuck> ;BJU International. 2008 Nov 1
• Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies.
  Belldegrun, A.S., Klatte, T., Shuch, B., LaRochelle, J.C., Miller, D.C., Said, J.W., Riggs, S.B., Zomorodian, N., Kabbinavar, F.F., Dekernion, J.B., Pantuck, A.J.> ;Cancer. 2008-11-01
• 123 citations
  Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival.
  Brian Shuch, Jeff C. La Rochelle, Tobias Klatte, Stephen B. Riggs, Weiqing Liu, Fairooz F. Kabbinavar, Allan J. Pantuck, Arie S. Belldegrun> ;Cancer. 2008 Oct 1
• 42 citations
  Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance.
  Brian Shuch, Jeff C. La Rochelle, Jon Wu, Tobias Klatte, Stephen B. Riggs, Fairooz F. Kabbinavar, Arie S. Belldegrun, Allan J. Pantuck> ;Cancer. 2008 Sep 15
• 3 citations
  The staging of renal cell carcinoma.
  Brian Shuch, Jeff C. La Rochelle, Allan J. Pantuck, Arie S. Belldegrun> ;Current Opinion in Urology. 2008 Sep 1
• Brain metastasis from renal cell carcinoma: Presentation, recurrence, survival and implications for systemic therapy.
  Shuch B, La Rochelle JC, Klatte T, Riggs SB, Kabbinavar FF, Pantuck AJ, Belldegrun AS> ;J. Clin. Oncol.. 2008-05-20
• Which pathological features of renal cell carcinoma have the greatest prognostic value
  Jeffrey C. La Rochelle, Arie S. Belldegrun> ;Nature Clinical Practice. Urology. 2008 Feb 1
• Changes in clinical skills education resulting from the introduction of the USMLE step 2 clinical skills (CS) examination.
  Gilliland WR, La Rochelle J, Hawkins R, Dillon GF, Mechaber AJ, Dyrbye L, Papp KK, Durning SJ> ;Med Teach. 2008-01-01
• Join now to see all